Timing for Safe Return to Sport after Medial Patellofemoral Ligament Reconstruction: The Role of a Functional Test Battery.


Journal

The journal of knee surgery
ISSN: 1938-2480
Titre abrégé: J Knee Surg
Pays: Germany
ID NLM: 101137599

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 6 9 2019
medline: 20 5 2021
entrez: 6 9 2019
Statut: ppublish

Résumé

The purpose of this article was to analyze clinical and functional results after medial patellofemoral ligament (MPFL) reconstruction and to establish if a computer-assisted physical test battery could determine a "safe timing" to return to sport. We hypothesized that "time-based" criteria to declare safe return to sport could not be reliable to predict functional recover. Fifty-eight young athletic patients were selected after isolated reconstruction of MPFL. The minimum follow-up was 8 months. All the patients were evaluated subjectively with Kujala and Short Form 36 (SF-36) scores and objectively through a standardized computer-assisted physical battery of seven tests (Back in Action, Corehab). No patient was lost at the end point of follow-up and no recurrence of patellar dislocation was reported. At 8 months, 31 patients (53.4%) returned to sport at preoperative levels, and 23 (39.6%) participated in sports at lower levels. The subjective evaluation reported an increase of Kujala (60-92.7) and SF-36 score (28.6/25.4-52.2/53.6). At computer-assisted objective assessment, only 23 patients (39.6%) fulfilled the criteria for safe return to sport, while 31 (53.4%) got an insufficient outcome and 4 (6.9%) failed to complete the test. From our data, clinical scores after MPFL reconstruction provide only little insight into return to sport. The introduction of a computer-assisted objective analysis in the decision-making process for proper return to sport is necessary to evaluate functional recovery and dynamic knee stability.

Identifiants

pubmed: 31486055
doi: 10.1055/s-0039-1696647
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-371

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Fabrizio Matassi (F)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Matteo Innocenti (M)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Cozzi Lepri Andrea (CL)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Luigi Zanna (L)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Joseph Malone (J)

Department of Internal Medicine/Orthopaedics, Torshovsdalen Legesenter and Oslo Legevakt, Oslo, Norway.

Roberto Civinini (R)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Massimo Innocenti (M)

University of Florence, Orthopaedic Clinic CTO, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH